Literature DB >> 16457000

Odontogenic signs and symptoms as predictors of odontogenic infection: a clinical trial.

Michael T Brennan1, Michael S Runyon, Jayne J Batts, Philip C Fox, M Louise Kent, Timothy L Cox, H James Norton, Peter B Lockhart.   

Abstract

BACKGROUND: The authors conducted a study to determine if odontogenic signs and symptoms in the emergency department predicted the development of overt odontogenic infection at a follow-up dental visit.
METHODS: One hundred ninety-five patients with odontalgia, but without overt signs of infection, were enrolled in a prospective, double-blind, randomized clinical trial. Data included dental diagnosis, pain characteristics, presence of caries and restorations, presence and size of periapical radiolucencies and other diagnostic test results.
RESULTS: Thirteen of 134 subjects for whom data were available had signs of infection at the follow-up visit. Subjects in the follow-up infected (FU-I) group had larger baseline radiolucencies than did subjects in the follow-up noninfected (FU-NI) group, and restorations were more prevalent for involved teeth in the FU-I group than in the FU-NI group.
CONCLUSIONS: A relationship exists between radiolucency size and the presence of amalgam restorations in patients who develop clinical signs of infection. Penicillin did not appear to influence this progression. CLINICAL IMPLICATIONS: Antibiotics are not effective in preventing the development of odontogenic infection when definitive dental therapy cannot be provided for acute pain in the absence of clinical signs of infection. Although the overall risk of developing infection is low, early treatment is indicated for teeth with larger periapical radiolucencies, amalgam restorations or both.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457000     DOI: 10.14219/jada.archive.2006.0022

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  5 in total

1.  Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.

Authors:  Georg Cachovan; Rainer H Böger; Ina Giersdorf; Olaf Hallier; Thomas Streichert; Munif Haddad; Ursula Platzer; Gerhard Schön; Karl Wegscheider; Ingo Sobottka
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

2.  The role of unfinished root canal treatment in odontogenic maxillofacial infections requiring hospital care.

Authors:  L Grönholm; K K Lemberg; L Tjäderhane; A Lauhio; C Lindqvist; R Rautemaa-Richardson
Journal:  Clin Oral Investig       Date:  2012-03-14       Impact factor: 3.573

3.  Oral lesions and lymphoproliferative disorders.

Authors:  P Castellarin; G Pozzato; G Tirelli; R Di Lenarda; M Biasotto
Journal:  J Oncol       Date:  2010-09-01       Impact factor: 4.375

Review 4.  Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults.

Authors:  Anwen L Cope; Nick Francis; Fiona Wood; Ivor G Chestnutt
Journal:  Cochrane Database Syst Rev       Date:  2018-09-27

5.  Moxifloxacin versus Clindamycin/Ceftriaxone in the management of odontogenic maxillofacial infectious processes: A preliminary, intrahospital, controlled clinical trial.

Authors:  Hansel Gómez-Arámbula; Antonio Hidalgo-Hurtado; Rosaura Rodríguez-Flores; Ana-María González-Amaro; Arturo Garrocho-Rangel; Amaury Pozos-Guillén
Journal:  J Clin Exp Dent       Date:  2015-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.